L‐type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non‐small cell lung cancer
- 1 June 2009
- journal article
- Published by Wiley in Histopathology
- Vol. 54 (7), 804-813
- https://doi.org/10.1111/j.1365-2559.2009.03300.x
Abstract
Aim: To evaluate the prognostic value of L‐type amino acid transporter 1 (LAT1) in patients with stage I non‐small cell lung cancer (NSCLC). Methods and results: A total of 282 consecutive patients with completely resected pathological stage I NSCLC were retrospectively reviewed. Expression of LAT1 and proliferative activity, as determined by the Ki67 labelling index, were also evaluated immunohistochemically and correlated with the prognosis of patients after complete resection of the tumour. LAT1 expression was positive in 114 patients (40%) [19% of adenocarcinoma (36 of 186 patients), 83% of squamous cell carcinoma (73 of 88 patients) and 63% of large cell carcinoma (five of eight patients)]. There was a significant correlation between LAT1 expression and Ki67 labelling index (γ = 0.6935, P < 0.001). LAT1 expression was significantly associated with gender, disease stage and pathological features. The 5‐year survival rate of LAT1+ patients (69.1%) was significantly worse than that of LAT1− patients (89.4%; P < 0.001). Multivariate analysis confirmed that positive expression of LAT1 was an independent factor for predicting a poor prognosis. Conclusion: LAT1 expression is a promising pathological factor for predicting the prognosis in patients with resectable stage I NSCLC.Keywords
This publication has 21 references indexed in Scilit:
- L‐type amino acid transporter 1 as a potential molecular target in human astrocytic tumorsInternational Journal of Cancer, 2006
- LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lungVirchows Archiv, 2005
- Expression of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat modelsJournal of Surgical Oncology, 2001
- Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell linesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- Lung cancerThe Lancet, 2000
- Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)Journal of Biological Chemistry, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Regulatory and molecular aspects of mammalian amino acid transportBiochemical Journal, 1994
- Role of amino acid transport and countertransport in nutrition and metabolism.Physiological Reviews, 1990
- Evidence for two Types of Mediation of Neutral Amino-Acid Transport in Ehrlich CellsNature, 1963